Patents by Inventor Joel Courter

Joel Courter has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CONJUGATES OF QUATERNIZED TUBULYSIN COMPOUNDS
    Publication number: 20240156969
    Abstract: Compounds and compositions are disclosed in which a quaternized drug unit is linked to a targeting ligand unit from which a tertiary amine-containing drug is released at the targeted site of action. Methods for treating diseases characterized by the targeted abnormal cells, such as cancer or an autoimmune disease using the compounds and compositions of the invention are also disclosed.
    Type: Application
    Filed: August 23, 2023
    Publication date: May 16, 2024
    Inventors: Patrick J. BURKE, Joel COURTER
  • Conjugates of quaternized tubulysin compounds
    Patent number: 11793880
    Abstract: Compounds and compositions are disclosed in which a quaternized drug unit is linked to a targeting ligand unit from which a tertiary amine-containing drug is released at the targeted site of action. Methods for treating diseases characterized by the targeted abnormal cells, such as cancer or an autoimmune disease using the compounds and compositions of the invention are also disclosed.
    Type: Grant
    Filed: November 22, 2021
    Date of Patent: October 24, 2023
    Assignee: Seagen Inc.
    Inventors: Patrick J. Burke, Joel Courter
  • CONJUGATES OF QUATERNIZED TUBULYSIN COMPOUNDS
    Publication number: 20220226482
    Abstract: Compounds and compositions are disclosed in which a quaternized drug unit is linked to a targeting ligand unit from which a tertiary amine-containing drug is released at the targeted site of action. Methods for treating diseases characterized by the targeted abnormal cells, such as cancer or an autoimmune disease using the compounds and compositions of the invention are also disclosed.
    Type: Application
    Filed: November 22, 2021
    Publication date: July 21, 2022
    Inventors: Patrick J. BURKE, Joel COURTER
  • Conjugates of quaternized tubulysin compounds
    Patent number: 11229708
    Abstract: Compounds and compositions are disclosed in which a quaternized drug unit is linked to a targeting ligand unit from which a tertiary amine-containing drug is released at the targeted site of action. Methods for treating diseases characterized by the targeted abnormal cells, such as cancer or an autoimmune disease using the compounds and compositions of the invention are also disclosed.
    Type: Grant
    Filed: December 2, 2016
    Date of Patent: January 25, 2022
    Assignee: SEAGEN INC.
    Inventors: Patrick J. Burke, Joel Courter
  • CONJUGATES OF QUATERNIZED TUBULYSIN COMPOUNDS
    Publication number: 20190015517
    Abstract: Compounds and compositions are disclosed in which a quaternized drug unit is linked to a targeting ligand unit from which a tertiary amine-containing drug is released at the targeted site of action. Methods for treating diseases characterized by the targeted abnormal cells, such as cancer or an autoimmune disease using the compounds and compositions of the invention are also disclosed.
    Type: Application
    Filed: December 2, 2016
    Publication date: January 17, 2019
    Applicant: SEATTLE GENETICS, INC.
    Inventors: Patrick J. Burke, Joel Courter